No Data
No Data
Oragenics Shares Investor Presentation Online
Express News | Oragenics Inc Says It May Offer Common Shares of up to $10 Mln
Express News | Oragenics Inc Says on October 11, Co Entered Into at-the-Market Sales Agreement With Dawson James Securities - SEC Filing
Express News | Oragenics Shares Are Trading Higher After the Company Provided a Corporate Update on Its 2024 Progress Including Developments of ONP-002, Its Lead Candidate for Concussions
Oragenics Shares Are Trading Higher After the Company Provided a Corporate Update on Its 2024 Progress Including Developments of ONP-002, Its Lead Candidate for Concussions.
Express News | Oragenics: In Preparation for Upcoming Phase II Clinical Trials Plans to Submit Australian Regulatory Submission Brochure During Q4
No Data
No Data